
Tags Archive Navigation
icon
-
Media ReleaseNovartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH
-
Media ReleaseNovartis to present broad range of portfolio data at ECTRIMS, reinforcing long-standing commitment to people living with multiple sclerosis
-
Media ReleaseNovartis Provides Update on AVXS-101 Intrathecal Clinical Development Program
-
Media ReleaseNovartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
-
Media ReleaseNovartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
-
Media ReleaseNovartis Kisqali® data show superior overall survival compared to fulvestrant and consistent efficacy across advanced breast cancer patient subgroups in MONALEESA-3
-
StoryToward improving the health and longevity of transplanted organs
-
StoryResearchers boost understanding of T-cell therapy in blood cancer
-
StoryCancer research drives breast cancer treatment forward
-
StoryCan data from a heart disease trial lead to a potential cancer treatment?
-
StoryGoing the extra mile to keep clinical trials on track during the COVID-19 pandemic
-
StoryTurning the sound up on patient voices in lung cancer research and development
Pagination
- 1
- 2
- 3
- 4
- › Next page